Insights from Preclinical Choice Models on Treating Drug Addiction.
about
Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.Effects of social reorganization on dopamine D2/D3 receptor availability and cocaine self-administration in male cynomolgus monkeys.Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.Effects of Acute and Chronic Treatments with Dopamine D2 and D3 Receptor Ligands on Cocaine versus Food Choice in Rats.Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.cAMP Response Element Binding Protein Expression in the Hippocampus of Rhesus Macaques with Chronic Ephedrine Addiction.
P2860
Insights from Preclinical Choice Models on Treating Drug Addiction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Insights from Preclinical Choice Models on Treating Drug Addiction.
@en
Insights from Preclinical Choice Models on Treating Drug Addiction.
@nl
type
label
Insights from Preclinical Choice Models on Treating Drug Addiction.
@en
Insights from Preclinical Choice Models on Treating Drug Addiction.
@nl
prefLabel
Insights from Preclinical Choice Models on Treating Drug Addiction.
@en
Insights from Preclinical Choice Models on Treating Drug Addiction.
@nl
P2860
P1476
Insights from Preclinical Choice Models on Treating Drug Addiction.
@en
P2093
Matthew L Banks
S Stevens Negus
P2860
P304
P356
10.1016/J.TIPS.2016.11.002
P577
2016-12-01T00:00:00Z